Guggenheim Capital’s AngioDynamics ANGO Stock Holding History

Guggenheim Capital’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-10,100	Closed	-$186K	–	2064
2019 Q3	$186K	Buy	+10,100	New	+$198K	﹤0.01%	2017
2019 Q2	–	Sell	-9,848	Closed	-$225K	–	2104
2019 Q1	$225K	Sell	9,848 -4,060	-29%	-$88.1K	﹤0.01%	2021
2018 Q4	$280K	Buy	+13,908	New	+$288K	﹤0.01%	1923
2018 Q2	–	Sell	-29,303	Closed	-$506K	–	2373
2018 Q1	$506K	Sell	29,303 -4,243	-13%	-$70.8K	﹤0.01%	2377
2017 Q4	$559K	Buy	+33,546	New	+$572K	﹤0.01%	2321
2016 Q4	–	Sell	-77,837	Closed	-$1.36M	–	2901
2016 Q3	$1.36M	Sell	77,837 -643	-0.8%	-$10.4K	﹤0.01%	1882
2016 Q2	$1.13M	Buy	78,480 +1,910	+2%	+$23.9K	﹤0.01%	1970
2016 Q1	$941K	Buy	76,570 +12,968	+20%	+$143K	﹤0.01%	2093
2015 Q4	$772K	Buy	+63,602	New	+$783K	﹤0.01%	2226
2015 Q1	–	Sell	-38,387	Closed	-$730K	–	3032
2014 Q4	$730K	Buy	+38,387	New	+$650K	﹤0.01%	2365

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Guggenheim Capital's ANGO Position: Q4 2019 in Review

Guggenheim Capital sold out of AngioDynamics (ANGO) in Q4 2019, closing a stake of 10,100 shares — an estimated $186K sold.

Guggenheim Capital first reported a position in ANGO in Q4 2014 and held it in 10 quarters. The position peaked at $1.36M in Q3 2016. 157 funds tracked by Wall St. Rank hold ANGO as of Q4 2019.

Guggenheim Capital reported no remaining AngioDynamics position as of Q4 2019 after selling out during the quarter.
Guggenheim Capital sold 10,100 AngioDynamics shares in Q4 2019, an estimated $186K.
Guggenheim Capital first reported a position in AngioDynamics in Q4 2014 and held it in 10 quarters.
Guggenheim Capital's AngioDynamics position peaked at $1.36M in Q3 2016.
157 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2019.

Based on Guggenheim Capital's 13F filing for Q4 2019, filed 14 Feb 2020.